The endoscopic submucosal dissection market is projected to reach USD 0.75 billion by 2030 from USD 0.50 billion in 2025, at a CAGR of 8.4% during the forecast period.
Technological advancements in endoscopic submucosal dissection (ESD) tools are significantly enhancing the procedure's clinical utility and safety, which, in turn, is driving market growth. Innovations such as hybrid knives that combine both injection and cutting capabilities have streamlined the dissection process and reduced procedural time. Additionally, traction-assisted systems have improved visualization and access to submucosal layers, making complex dissections more manageable.
High-definition and narrow-band imaging (NBI) endoscopes have further enhanced the detection of lesions and assessment of margins, resulting in increased procedural accuracy and better patient outcomes. Companies like Olympus and Fujifilm are heavily investing in platform-specific innovations, integrating energy delivery systems, ergonomic endoscope designs, and AI-based visualization aids.
These developments are reducing the technical barriers traditionally associated with ESD, enabling broader adoption in non-academic and community healthcare settings. As these tools become more intuitive and standardized, they are facilitating the learning process for new practitioners, ultimately making ESD more accessible and preferred for the management of early-stage gastrointestinal tumors worldwide.
By product, the gastroscopes & endoscopes segment accounted for the largest share of the market in 2024.
The market for endoscopic submucosal dissection (ESD) is categorized by product type into gastroscopes & endoscopes, knives, injection agents, tissue retractors, grasping clips, and other products. In 2024, the segment for gastroscopes & endoscopes held the largest share of the global ESD market.
Recent advancements in high-definition (HD) and 4K ultra-high-definition (UHD) imaging technologies have transformed ESD procedures by providing superior optical clarity and detailed visualization. Features such as narrow-band imaging (NBI), magnification endoscopy, and 4K scopes significantly enhance the detection of lesions, delineation of margins, and overall procedural accuracy. These imaging enhancements reduce the likelihood of diagnostic errors and allow for more precise dissection, ultimately leading to improved patient outcomes. Consequently, gastroscopes & endoscopes play a vital role in these advancements, which is why they dominate the market share in the ESD sector, driven by their essential contribution to the success of these procedures.
Based on indications, the stomach cancer segment dominated the ESD market in 2024.
Based on indications, the ESD market is divided into three categories: stomach cancer, colon cancer, and esophageal cancer. In 2024, stomach cancer accounted for the largest share of the ESD market. Strong clinical evidence supports ESD as the gold standard for treating mucosal and superficial submucosal gastric tumors. Long-term studies have shown that ESD achieves high rates of en bloc resection, minimal local recurrence, and excellent organ preservation, especially when compared to traditional surgery. These outcomes are particularly significant for early-stage stomach cancers, where a curative approach without major surgery is preferred. Consequently, the stomach cancer segment leads the ESD market, driven by strong clinical validation and high procedural volumes in the management of gastric lesions.
Based on region, the Asia Pacific held the largest market share in 2024.
The Asia Pacific region is projected to hold the largest share of the ESD market during the forecast period. Government-funded screening programs in Japan and South Korea are actively promoting the early detection of gastric and colorectal lesions through endoscopy, which has significantly increased ESD volumes. This region has also been at the forefront of adopting advanced medical technology to enhance patient care and safety.
A breakdown of the primary participants (supply side) for the endoscopic submucosal dissection market referred to in this report is provided below:
• By Company Type: Tier 1 (34%), Tier 2 (38%), and Tier 3 (28%)
• By Designation: C-level Executives (26%), Directors (35%), and Others (39%)
• By Region: North America (17%), Europe (39%), Asia Pacific (28%), Latin America (8%), Middle East & Africa (3%), and GCC Countries (5%)
Prominent players in the endoscopic submucosal dissection market are Olympus Corporation (Japan), FUJIFILM Holdings Corporation (Japan), Medtronic (Ireland), Boston Scientific Corporation (US), and Sumitomo Bakelite Co., Ltd. (Japan).
Research Coverage
The report assesses the endoscopic submucosal dissection market, estimating its size and future growth potential across various segments, including products, indications, end users, and regions. Additionally, the report features a competitive analysis of key players in the market, along with company profiles, product offerings, recent developments, and essential market strategies.
Reasons to Buy the Report
The report will provide valuable data on revenue estimates for the overall endoscopic submucosal dissection market and its subsegments, benefiting both market leaders and new entrants. It will help stakeholders understand the competitive landscape, enabling them to better position their businesses and develop effective go-to-market strategies. Additionally, the report will give stakeholders insights into market trends, including key drivers, challenges, restraints, and opportunities.
This report provides insights into the following points:
Analysis of key drivers (increasing use of endoscopy in detection and treatment procedures and rising prevalence of cancer), restraints (dearth of skilled professionals and high overhead cost of ESD procedures with limited reimbursements), opportunities (growing demand for minimally invasive procedures, growing investments in R&D of endoscopy technology, and expected increase in adoption of and preference for ESD procedures in developing countries), and challenges (higher rate of complications and risk of post-operative infections).
• Product Enhancement/Innovation: Comprehensive details about product launches and anticipated trends in the global ESD market.
• Market Development: Thorough knowledge and analysis of the profitable rising markets by product, indication, end user, and region.
• Market Diversification: Comprehensive information about newly launched products and services, expanding markets, current advancements, and investments in the global ESD market.
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings, and capacities of the major competitors in the global ESD market.
圖表清單 List of Tables & Figures
TABLE 1 STANDARD CURRENCY CONVERSION RATES 26
TABLE 2 RISK ASSESSMENT: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET 42
TABLE 3 GLOBAL CANCER INCIDENCE FOR GERIATRIC POPULATION (65–85+),
2020 VS. 2040 52
TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 57
TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 58
TABLE 6 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT
AGENCIES, AND OTHER ORGANIZATIONS 58
TABLE 7 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: ROLE IN ECOSYSTEM 62
TABLE 8 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET:
PORTER’S FIVE FORCES ANALYSIS 64
TABLE 9 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT, 2024 (USD) 67
TABLE 10 AVERAGE SELLING PRICE TREND OF KNIVES, BY REGION, 2022–2024 (USD) 68
TABLE 11 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: KEY PATENTS, 2023–2025 70
TABLE 12 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET:
CONFERENCES AND EVENTS, 2025–2026 74
TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 75
TABLE 14 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 76
TABLE 15 IMPORT DATA FOR HS CODE 901890 BY COUNTRY, 2020–2024 (USD THOUSAND) 78
TABLE 16 EXPORT DATA FOR HS CODE 901890, BY COUNTRY,
2020–2024 (USD THOUSAND) 79
TABLE 17 TYPES OF ELECTROSURGICAL KNIVES: FEATURES & USE CASES 80
TABLE 18 KEY COMPANIES IMPLEMENTING AI 86
TABLE 19 US-ADJUSTED RECIPROCAL TARIFF RATES 88
TABLE 20 KEY PRODUCT-RELATED TARIFFS FOR ENDOSCOPIC SUBMUCOSAL DISSECTION 88
TABLE 21 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 93
TABLE 22 GASTROSCOPES & COLONOSCOPES: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 94
TABLE 23 KNIVES: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 95
TABLE 24 KNIVES: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION,
2023–2030 96
TABLE 25 INJECTION AGENTS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 97
TABLE 26 INJECTION AGENTS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY REGION, 2023–2030 98
TABLE 27 TISSUE RETRACTORS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 99
TABLE 28 TISSUE RETRACTORS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY REGION, 2023–2030 99
TABLE 29 GRASPERS/CLIPS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 100
TABLE 30 GRASPERS/CLIPS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY REGION, 2023–2030 101
TABLE 31 OTHER PRODUCTS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 102
TABLE 32 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION,
2023–2030 (USD MILLION) 104
TABLE 33 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION,
2022 (NUMBER OF PROCEDURES) 104
TABLE 34 ESTIMATED NUMBER OF NEW CASES OF STOMACH CANCER,
BY REGION (2022–2040) 105
TABLE 35 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR STOMACH CANCER,
BY COUNTRY, 2023–2030 (USD MILLION) 106
TABLE 36 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR STOMACH CANCER,
BY REGION, 2024 (NUMBER OF PROCEDURES) 106
TABLE 37 ESTIMATED NUMBER OF NEW CASES OF COLON CANCER,
BY REGION (2022–2040) 107
TABLE 38 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR COLON CANCER,
BY COUNTRY, 2023–2030 (USD MILLION) 108
TABLE 39 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR COLON CANCER,
BY REGION, 2024 (NUMBER OF PROCEDURES) 108
TABLE 40 ESTIMATED NUMBER OF NEW CASES OF ESOPHAGEAL CANCER, BY REGION (2022–2040) 109
TABLE 41 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR ESOPHAGEAL CANCER,
BY COUNTRY, 2023–2030 (USD MILLION) 110
TABLE 42 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR ESOPHAGEAL CANCER,
BY REGION, 2024 (NUMBER OF PROCEDURES) 110
TABLE 43 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER,
2023–2030 (USD MILLION) 112
TABLE 44 HOSPITALS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 113
TABLE 45 SPECIALTY CLINICS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 115
TABLE 46 AMBULATORY SURGICAL CENTERS: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 116
TABLE 47 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR OTHER END USERS,
BY COUNTRY, 2023–2030 (USD MILLION) 117
TABLE 48 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION,
2023–2030 (USD MILLION) 119
TABLE 49 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 121
TABLE 50 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 121
TABLE 51 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION) 122
TABLE 52 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY END USER, 2023–2030 (USD MILLION) 122
TABLE 53 JAPAN: MACROECONOMIC INDICATORS 123
TABLE 54 JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 123
TABLE 55 JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION,
2023–2030 (USD MILLION) 124
TABLE 56 JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY END USER, 2023–2030 (USD MILLION) 124
TABLE 57 CHINA: MACROECONOMIC INDICATORS 125
TABLE 58 CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 125
TABLE 59 CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY INDICATION, 2023–2030 (USD MILLION) 125
TABLE 60 CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY END USER, 2023–2030 (USD MILLION) 126
TABLE 61 INDIA: MACROECONOMIC INDICATORS 127
TABLE 62 INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 127
TABLE 63 INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY INDICATION, 2023–2030 (USD MILLION) 127
TABLE 64 INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY END USER, 2023–2030 (USD MILLION) 128
TABLE 65 SOUTH KOREA: MACROECONOMIC INDICATORS 129
TABLE 66 SOUTH KOREA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 129
TABLE 67 SOUTH KOREA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY INDICATION, 2023–2030 (USD MILLION) 129
TABLE 68 SOUTH KOREA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY END USER, 2023–2030 (USD MILLION) 130
TABLE 69 AUSTRALIA: MACROECONOMIC INDICATORS 130
TABLE 70 AUSTRALIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 131
TABLE 71 AUSTRALIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY INDICATION, 2023–2030 (USD MILLION) 131
TABLE 72 AUSTRALIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY END USER, 2023–2030 (USD MILLION) 131
TABLE 73 REST OF ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 132
TABLE 74 REST OF ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY INDICATION, 2023–2030 (USD MILLION) 133
TABLE 75 REST OF ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY END USER, 2023–2030 (USD MILLION) 133
TABLE 76 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 135
TABLE 77 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 135
TABLE 78 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY INDICATION, 2023–2030 (USD MILLION) 135
TABLE 79 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY END USER, 2023–2030 (USD MILLION) 136
TABLE 80 US: MACROECONOMIC INDICATORS 137
TABLE 81 US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 137
TABLE 82 US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION,
2023–2030 (USD MILLION) 137
TABLE 83 US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER,
2023–2030 (USD MILLION) 138
TABLE 84 AGE-STANDARDIZED INCIDENCE RATES (ASIR) FOR SELECTED CANCERS IN MEN AND WOMEN IN CANADA, 2020 VS. 2040 139
TABLE 85 CANADA: MACROECONOMIC INDICATORS 140
TABLE 86 CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 140
TABLE 87 CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION) 140
TABLE 88 CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER,
2023–2030 (USD MILLION) 141
TABLE 89 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 142
TABLE 90 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 142
TABLE 91 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION) 143
TABLE 92 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER,
2023–2030 (USD MILLION) 143
TABLE 93 GERMANY: MACROECONOMIC INDICATORS 144
TABLE 94 GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 144
TABLE 95 GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION) 145
TABLE 96 GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030 (USD MILLION) 145
TABLE 97 FRANCE: MACROECONOMIC INDICATORS 146
TABLE 98 FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 146
TABLE 99 FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION) 147
TABLE 100 FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER,
2023–2030 (USD MILLION) 147
TABLE 101 UK: MACROECONOMIC INDICATORS 148
TABLE 102 UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 148
TABLE 103 UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION,
2023–2030 (USD MILLION) 149
TABLE 104 UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER,
2023–2030 (USD MILLION) 149
TABLE 105 ITALY: MACROECONOMIC INDICATORS 150
TABLE 106 ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 150
TABLE 107 ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION,
2023–2030 (USD MILLION) 150
TABLE 108 ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER,
2023–2030 (USD MILLION) 151
TABLE 109 SPAIN: MACROECONOMIC INDICATORS 151
TABLE 110 SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 152
TABLE 111 SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION,
2023–2030 (USD MILLION) 152
TABLE 112 SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER,
2023–2030 (USD MILLION) 152
TABLE 113 REST OF EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 153
TABLE 114 REST OF EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY INDICATION, 2023–2030 (USD MILLION) 154
TABLE 115 REST OF EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY END USER, 2023–2030 (USD MILLION) 154
TABLE 116 LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 155
TABLE 117 LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 156
TABLE 118 LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY INDICATION, 2023–2030 (USD MILLION) 156
TABLE 119 LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY END USER, 2023–2030 (USD MILLION) 156
TABLE 120 BRAZIL: MACROECONOMIC INDICATORS 157
TABLE 121 BRAZIL: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 157
TABLE 122 BRAZIL: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION,
2023–2030 (USD MILLION) 158
TABLE 123 BRAZIL: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER,
2023–2030 (USD MILLION) 158
TABLE 124 MEXICO: MACROECONOMIC INDICATORS 159
TABLE 125 MEXICO: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 159
TABLE 126 MEXICO: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2023–2030 (USD MILLION) 159
TABLE 127 MEXICO: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER,
2023–2030 (USD MILLION) 160
TABLE 128 REST OF LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 161
TABLE 129 REST OF LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY INDICATION, 2023–2030 (USD MILLION) 161
TABLE 130 REST OF LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY END USER, 2023–2030 (USD MILLION) 161
TABLE 131 MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 163
TABLE 132 MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY INDICATION, 2023–2030 (USD MILLION) 163
TABLE 133 MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY END USER, 2023–2030 (USD MILLION) 163
TABLE 134 GCC COUNTRIES: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 165
TABLE 135 GCC COUNTRIES: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY INDICATION, 2023–2030 (USD MILLION) 165
TABLE 136 GCC COUNTRIES: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET,
BY END USER, 2023–2030 (USD MILLION) 165
TABLE 137 KEY DEVELOPMENTS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, JANUARY 2021–JUNE 2025 167
TABLE 138 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET : DEGREE OF COMPETITION 170
TABLE 139 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET : REGION FOOTPRINT 175
TABLE 140 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: PRODUCT FOOTPRINT 176
TABLE 141 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: INDICATION FOOTPRINT 177
TABLE 142 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: END USER FOOTPRINT 177
TABLE 143 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: KEY STARTUPS/SMES 180
TABLE 144 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY REGION 181
TABLE 145 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET : COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY PRODUCT 181
TABLE 146 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: PRODUCT LAUNCHES,
JANUARY 2021–JUNE 2025 184
TABLE 147 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DEALS,
JANUARY 2021–JUNE 2025 185
TABLE 148 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: EXPANSIONS,
JANUARY 2021–JUNE 2025 186
TABLE 149 OLYMPUS CORPORATION: BUSINESS OVERVIEW 187
TABLE 150 OLYMPUS CORPORATION: PRODUCTS OFFERED 188
TABLE 151 OLYMPUS CORPORATION: DEALS, JANUARY 2021–JUNE 2025 189
TABLE 152 OLYMPUS CORPORATION: EXPANSIONS, JANUARY 2021–JUNE 2025 190
TABLE 153 MEDTRONIC: COMPANY OVERVIEW 191
TABLE 154 MEDTRONIC: PRODUCTS OFFERED 192
TABLE 155 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW 194
TABLE 156 FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED 195
TABLE 157 FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–JUNE 2025 195
TABLE 158 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2021–JUNE 2025 196
TABLE 159 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 197
TABLE 160 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 198
TABLE 161 SUMITOMO BAKELITE CO., LTD.: BUSINESS OVERVIEW 200
TABLE 162 SUMITOMO BAKELITE CO., LTD.: PRODUCTS OFFERED 201
TABLE 163 CREO MEDICAL GROUP PLC: BUSINESS OVERVIEW 202
TABLE 164 CREO MEDICAL GROUP PLC: PRODUCTS OFFERED 203
TABLE 165 CREO MEDICAL GROUP PLC: DEALS, JANUARY 2021–JUNE 2025 203
TABLE 166 CREO MEDICAL GROUP PLC: EXPANSIONS, JANUARY 2021–JUNE 2025 203
TABLE 167 HOYA CORPORATION: BUSINESS OVERVIEW 204
TABLE 168 HOYA CORPORATION: PRODUCTS OFFERED 205
TABLE 169 CONMED CORPORATION: BUSINESS OVERVIEW 207
TABLE 170 CONMED CORPORATION: PRODUCTS OFFERED 208
TABLE 171 STERIS: COMPANY OVERVIEW 209
TABLE 172 STERIS: PRODUCTS OFFERED 210
TABLE 173 STERIS: DEALS 211
TABLE 174 MTW ENDOSKOPIE MANUFAKTUR: BUSINESS OVERVIEW 212
TABLE 175 MTW ENDOSKOPIE MANUFAKTUR: PRODUCTS OFFERED 212
TABLE 176 OVESCO ENDOSCOPY AG: BUSINESS OVERVIEW 213
TABLE 177 OVESCO ENDOSCOPY AG: PRODUCTS OFFERED 213
TABLE 178 ZEON MEDICAL INC.: BUSINESS OVERVIEW 214
TABLE 179 ZEON MEDICAL INC.: PRODUCTS OFFERED 214
TABLE 180 MICRO-TECH ENDOSCOPY: BUSINESS OVERVIEW 215
TABLE 181 MICRO-TECH ENDOSCOPY: PRODUCTS OFFERED 215
TABLE 182 MICRO-TECH ENDOSCOPY: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025 216
TABLE 183 KARL STORZ SE & CO. KG.: BUSINESS OVERVIEW 217
TABLE 184 KARL STORZ SE & CO. KG.: PRODUCTS OFFERED 217
TABLE 185 COOK MEDICAL: BUSINESS OVERVIEW 218
TABLE 186 COOK MEDICAL: PRODUCTS OFFERED 218
TABLE 187 COOK MEDICAL: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025 219
TABLE 188 LEO MEDICAL CO., LTD.: COMPANY OVERVIEW 219
TABLE 189 ERBE ELEKTROMEDIZIN GMBH: COMPANY OVERVIEW 220
TABLE 190 TAEWOONG MEDICAL CO., LTD.: COMPANY OVERVIEW 220
TABLE 191 DCC HEALTHCARE: COMPANY OVERVIEW 221
TABLE 192 KOSSEN CO., LTD.: COMPANY OVERVIEW 221
TABLE 193 INNOVAMEDICA S.P.A.: COMPANY OVERVIEW 222
TABLE 194 JIANGSU VEDKANG MEDICAL SCIENCE AND TECHNOLOGY CO., LTD.:
COMPANY OVERVIEW 223
TABLE 195 HANGZHOU AGS MEDICAL TECHNOLOGICAL CO., LTD.: COMPANY OVERVIEW 224
TABLE 196 BEIJING ZKSK TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 224
TABLE 197 UPEX-MED CO., LTD.: COMPANY OVERVIEW 225
FIGURE 1 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SEGMENTATION 24
FIGURE 2 RESEARCH DESIGN 28
FIGURE 3 PRIMARY SOURCES 30
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND
DEMAND-SIDE PARTICIPANTS 32
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 33
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE):
BY END USER, DESIGNATION, AND REGION 33
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 34
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: OLYMPUS CORPORATION 35
FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION: ENDOSCOPIC SUBMUCOSAL
DISSECTION MARKET (2024) 36
FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025–2030) 37
FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 38
FIGURE 12 TOP-DOWN APPROACH 38
FIGURE 13 DATA TRIANGULATION METHODOLOGY 40
FIGURE 14 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT,
2025 VS. 2030 (USD MILLION) 43
FIGURE 15 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION,
2025 VS. 2030 (USD MILLION) 44
FIGURE 16 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER,
2025 VS. 2030 (USD MILLION) 44
FIGURE 17 GEOGRAPHIC SNAPSHOT OF ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET 45
FIGURE 18 INCREASING USE OF ENDOSCOPY IN DETECTION AND TREATMENT PROCEDURES TO DRIVE MARKET GROWTH 46
FIGURE 19 GASTROSCOPES & COLONOSCOPES HELD LARGEST SHARE OF
ASIA PACIFIC MARKET IN 2024 47
FIGURE 20 MARKET IN CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 48
FIGURE 21 ASIA PACIFIC TO BE LARGEST ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET 48
FIGURE 22 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATE
DURING FORECAST PERIOD 49
FIGURE 23 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 50
FIGURE 24 GLOBAL CANCER INCIDENCE, 2022–2050 51
FIGURE 25 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: ECOSYSTEM ANALYSIS 62
FIGURE 26 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: VALUE CHAIN ANALYSIS 63
FIGURE 27 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET:
PORTER’S FIVE FORCES ANALYSIS 64
FIGURE 28 AVERAGE SELLING PRICE TREND OF KNIVES, BY REGION, 2022–2024 (USD) 68
FIGURE 29 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: TOP PATENT OWNERS/APPLICANTS AND NUMBER OF PATENTS GRANTED,
JANUARY 2015–JUNE 2025 69
FIGURE 30 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET:
STAKEHOLDERS IN SUPPLY CHAIN 73
FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 75
FIGURE 32 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 75
FIGURE 33 IMPORT DATA FOR HS CODE 901890 COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 77
FIGURE 34 EXPORT DATA FOR HS CODE 901890 COMPLIANT PRODUCTS,
BY COUNTRY, 2020-2024 79
FIGURE 35 KEY FEATURES OF GEN AI IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET 86
FIGURE 36 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: FUNDING AND NUMBER OF DEALS, 2019–2023 (USD MILLION) 90
FIGURE 37 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: VALUE OF INVESTOR DEALS,
BY KEY PLAYER, 2019–2023 (USD MILLION) 90
FIGURE 38 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: NUMBER OF
INVESTOR DEALS, BY KEY PLAYER, 2019–2023 91
FIGURE 39 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SNAPSHOT 120
FIGURE 40 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SNAPSHOT 134
FIGURE 41 REVENUE ANALYSIS OF TOP PLAYERS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, 2020–2024 (USD MILLION) 169
FIGURE 42 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 170
FIGURE 43 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 173
FIGURE 44 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: COMPANY FOOTPRINT 174
FIGURE 45 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 179
FIGURE 46 EV/EBITDA OF KEY VENDORS 182
FIGURE 47 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 183
FIGURE 48 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: BRAND/PRODUCT COMPARISON 183
FIGURE 49 OLYMPUS CORPORATION: COMPANY SNAPSHOT 188
FIGURE 50 MEDTRONIC: COMPANY SNAPSHOT 192
FIGURE 51 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT 194
FIGURE 52 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 198
FIGURE 53 SUMITOMO BAKELITE CO., LTD.: COMPANY SNAPSHOT 200
FIGURE 54 CREO MEDICAL GROUP PLC: COMPANY SNAPSHOT 202
FIGURE 55 HOYA CORPORATION: COMPANY SNAPSHOT 205
FIGURE 56 CONMED CORPORATION: COMPANY SNAPSHOT 208
FIGURE 57 STERIS: COMPANY SNAPSHOT 210